Formed by a group of seasoned medical tech startup founders, Neuro42 is a technology company developing solutions that push the frontiers of brain imaging and neurological condition treatments. Its products help identify and treat conditions such as strokes, brain tumours, hydrocephalus and epilepsy.
One of its significant products is a portable MRI and robotic intervention platform that helps practitioners screen, diagnose and live image-guided procedures. With minimal setup required, the software integrates into preexisting medical workflows, optimizing accuracy and diagnoses. 2024 funding is helping the company to scale its product and reach more patients.
Steph
Company Specialist at Welcome to the Jungle